Successful congress for EuCornea with excellent programme

Speaking at the Opening Ceremony of the 4th EuCornea Congress in Amsterdam, The Netherlands, Dr José Güell said the success of EuCornea was due to the high calibre of the scientific programme.
“As president of EuCornea it gives me great pleasure to welcome you to Amsterdam for the 4th EuCornea congress,” said Dr Güell. “I am pleased to announce that this looks set to be another successful congress with almost 660 ophthalmologists attending. “I would like to thank all the organisers and speakers for their invaluable role in creating such a high calibre scientific programme for the 4th Congress.”
Dr Güell said the congress promised to deliver an excellent programme with world leaders in the field of cornea and ocular surface disease speaking across 12 symposia, six courses and 12 free paper sessions.
“At a time when we all have to choose carefully which congresses we attend, offering delegates more than one meeting at the same time seems to be very valuable,” said Dr Güell.
Tags: intraocular pressure, tissue types
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.